Hong Kong Market Wrap: Kaisa's Windfall and Jingrui's Liquidation Highlight Sector ExtremesGlobal Report·Aug 5 at 04:12 AM01638+4.88%021810.00%
"MABPHARM" achieved a net profit of 57.13 million RMB for the entire year, turning a loss into a profitAASTOCKS·Mar 26 at 09:27 AM021810.00%
Hong Kong Stock Movement Quick Report: QUANTGROUP surged 22.28%, FIT HON TENG and XXF rose over 10%HK Stock Alerts·Mar 17 at 11:00 PM02685+0.12%01759-0.72%
Hong Kong Stock Movement Quick Report: BRIGHT SMART and MOBVISTA surged over 20%, while DEEPEXI TECH plummeted 17%HK Stock Alerts·Mar 12 at 10:00 PM01428+3.09%01860-3.70%
Insiders the biggest winners as Mabpharm Limited's (HKG:2181) market cap rises to HK$2.3bSimplywall·Jan 9 at 06:38 PM021810.00%
MABPHARM-B: Zhang Yanyun has been appointed as the Chief Independent Non-Executive DirectorZhitong·Oct 31, 2025 at 06:10 AM021810.00%
MABPHARM's interim net profit is 2.9 million RMB, turning losses into profitsAASTOCKS·Aug 28, 2025 at 03:40 PM021810.00%
MABPHARM-B released its interim results, with a profit attributable to shareholders of HKD 2.898 million, turning from a loss to a profit year-on-yearZhitong·Aug 28, 2025 at 07:11 AM021810.00%
Why Investors Shouldn't Be Surprised By Mabpharm Limited's (HKG:2181) Low P/SSimplywall·Jul 28, 2025 at 07:10 PM021810.00%
